Freedom to Operate for Autoinjectors: Why Sourcing Teams Ask for It Before the Price
Published 2026-10-27 · Keywords: autoinjector FTO
Freedom to operate — FTO — has quietly become the first gate in autoinjector sourcing, ahead of price and sometimes ahead of quality system. The reason is structural: the leading device platforms are protected by dense patent families, and a buyer who adopts an infringing design inherits the problem at the worst possible moment — after launch, with patients on the device. Asking for the FTO answer first costs one email; discovering the answer later costs the program.
Why this category is different
Device patents in this field do not just cover mechanisms — they cover activation workflows, needle-shield behaviours, dose-display arrangements and container interfaces, often across dozens of jurisdictions. The established players (SHL, Ypsomed, Owen Mumford, Haselmeier and others) built these families over decades; they are mentioned here as the neutral fact of the landscape, not as a comparison. A new or copied design that walks through one of those families can trigger injunctions, border detentions or forced redesigns — any of which lands on the buyer who put the device into the market.
What a sourcing team should actually request
| Ask | What a good answer looks like |
|---|---|
| “Does this platform carry your own patent position?” | A list of the supplier’s or partner’s own granted/pending patents for the platform |
| “How does it sit against the major families?” | A design-around statement — which known claim areas the design deliberately avoids |
| “Will you warrant non-infringement to the extent possible?” | A contract clause, scoped honestly (no supplier can warrant against all future assertions) |
| “Who owned the design at each step?” | Clean chain of title across any prior development partners |
What a good answer does not look like: “yes, no problem”, a certificate, or silence. FTO is answered with documents and claim-level reasoning, or it is not answered.
The buyer-side work that remains
An FTO statement from a supplier is an input to your legal review, not a substitute for it. Your counsel decides the jurisdictions that matter for your launch, reads the design-around reasoning against the active claims, and sets the risk position. Suppliers who understand this division hand over well-organized inputs and stop at the boundary — which is itself a signal of how they will behave on quality documents.
How to sequence it
FTO first, quality system second, price third — in that order, in writing, before samples. Programs that invert the sequence tend to re-invert it again at the audit, with the legal team’s invoice attached.
What this does not cover
Patent validity opinions, infringement litigation and jurisdiction strategy are legal work for your counsel. This article covers what to request from a device supplier and how to read the answer.
Next step: request the FTO document set for the platform you are evaluating — own-patent list and design-around statement — and ask for the compliance scope in writing; certificate copies follow with the order documentation. Start the inquiry.
Related reading
Talk to NOVIXPEN about your program
Send your container format, annual volume and target market — we reply with the platform match, documentation set and written quotation within one working day.
Start the inquiry